A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PA / P. aeruginosa

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PA  (>> Co-occurring Abbreviation)
Long Form:   P. aeruginosa
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Biological and microbiological interactions of Ti-35Nb-7Zr alloy and its basic elements on bone marrow stromal cells: good prospects for bone tissue engineering. BMSC, EDS, Nb, SA, SEM, Ti, Zr
2020 Do contact precautions reduce the incidence of ICU-acquired Pseudomonas aeruginosa infections? The DPCPYO cluster-randomized crossover trial. CI, CP, ICUs, IP, SDI, TI
2019 Anti-PcrV titers in non-cystic fibrosis patients with Pseudomonas aeruginosa respiratory tract infection. ---
2019 Corticosteroid eye drop instillation aggravates the development of Acanthamoeba keratitis in rabbit corneas inoculated with Acanthamoeba and bacteria. AK, BSP
2019 Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms. CIP
2019 In vitro evaluation of Pseudomonas aeruginosa chronic lung infection models: Are agar and calcium-alginate beads interchangeable? ATB, CIP, TOB
2019 In Vivo Proteome of Pseudomonas aeruginosa in Airways of Cystic Fibrosis Patients. CF
2019 The thiocyanate analog selenocyanate is a more potent antimicrobial pro-drug that also is selectively detoxified by the host. Bcc, CF, LPO, MRSA, TrxR
2018 Bacterial leakage in external hexagon implants with and without the interposition of a sealing-connector. Aa
10  2018 Dynamic clinical prediction models for discrete time-to-event data with competing risks-A case study on the OUTCOMEREA database. VAP
11  2018 Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections. aOR, MDR-PA, XDR-PA
12  2018 VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis. FPR2, LXA4, MPO, RvD1, VIP
13  2017 Allergen specific immunotherapy enhanced defense against bacteria via TGF-beta1-induced CYP27B1 in asthma. CRAMP, SIT
14  2017 Graphene oxide as an efficient antimicrobial nanomaterial for eradicating multi-drug resistant bacteria in vitro and in vivo. AM, E. coli, GO, KP, MDR, PMN
15  2017 P. aeruginosa colonization at ICU admission as a risk factor for developing P. aeruginosa ICU pneumonia. CI, SHR
16  2016 Application of Pharmacodynamic Profiling for the Selection of Optimal beta-lactam Regimens in a Large University Hospital. AB, ATBs, CFR, EC, GNB, KP, MIC, PI
17  2016 Inhibition of P. aeruginosa c-di-GMP phosphodiesterase RocR and swarming motility by a benzoisothiazolinone derivative. DGCs, PDEs
18  2015 One-year safety and efficacy of tobramycin powder for inhalation in patients with cystic fibrosis. AEs, CF, MIC
19  2015 Pectin-Derived Acidic Oligosaccharides Improve the Outcome of Pseudomonas aeruginosa Lung Infection in C57BL/6 Mice. OS, pAOS
20  2015 Virulence Attributes and Host Response Assays for Determining Pathogenic Potential of Pseudomonas Strains Used in Biotechnology. Pf, Pp, Ps
21  2014 Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections. CF, PCD, ROC
22  2014 IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. BALT, FDCs, MVA
23  2013 Antimicrobial Pressure of Ciprofloxacin and Gentamicin on Biofilm Development by an Endoscope-Isolated Pseudomonas aeruginosa. BC, CIP, GM
24  2011 P. aeruginosa infection increases morbidity in experimental cholesteatomas. ---
25  2011 Persistency of Pseudomonas aeruginosa in sputum cultures and clinical outcomes in adult patients with cystic fibrosis. ---
26  2011 The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis. CF, PFTs
27  2010 Array lead zirconate titanate/glass piezoelectric microcantilevers for real-time detection of Bacillus anthracis with 10 spores/ml sensitivity and 1/1000 selectivity in bacterial mixtures. BA, PEMSs, SA
28  2010 Global analysis of disulfide bond proteins in Pseudomonas aeruginosa exposed to hydrogen peroxide and gamma rays. DSBP, qPCR
29  2009 Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice. AZM, CF
30  2005 Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections. MPa, NBSI, PPa
31  2005 Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. SIRS
32  2005 [Study of rat beta-defensin-2 gene and protein expression in ventilator-associated pneumonia]. BALF, CMV, MV, rBD2, RT-PCR, VAP
33  2003 Induction of apoptosis in macrophage cell line, J774, by the cell-free supernatant from Pseudomonas aeruginosa. TUNEL
34  2003 [Comparative in vitro bacteriostatic and bactericidal activity of levofloxacin and ciprofloxacin against urinary tract pathogens determined by MIC, MBC, Time-Kill curves and bactericidal index analysis]. EC, PM
35  1996 Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. ---
36  1995 Alginate regulatory and biosynthetic gene homologs in Pseudomonas putida WCS358: correlation with the siderophore regulatory gene pfrA. Pp
37  1994 Cloning, analysis and expression of an rpoS homologue gene from Pseudomonas aeruginosa PAO1. ---
38  1975 Comparison of amikacin and gentamicin. EC